INVENTIVA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 EUR | -1.32% |
|
-5.96% | -26.74% |
| Apr. 22 | Inventiva: UBS Group falls below 5% threshold | CF |
| Apr. 18 | Transcript : Inventiva S.A. - Special Call |
Chart calendar Inventiva
3f177f48bd5e15e7677.UhSludTK22cqQKTQGRSGN-M8DWm94NACwUbXadxFa-c.OW7jwKa5hFdAdZfkTW3Ieq9IfQv-2b4viyDjP-4OBdNmfsKIsa-CPloJ8Q~f0462287138d9c0d7cd99a6973de0a5f
Upcoming events on Inventiva
Past events on Inventiva
| 2024-04-14 | Accelerating Bio-Innovation Conference |
| 2024-04-03 | Investor Access Conference |
| 2024-04-03 | Liver Connect Conference |
| 2024-03-28 08:00 am | Q4 2023 Earnings Call |
| 2024-03-27 04:00 pm | Q4 2023 Earnings Release |
| 2024-03-19 08:00 am | Lanifibranor and Empagliflozin LEGEND Phase II Combination Trial Results Call |
| 2024-03-17 | Paris Hepatology Conference |
| 2024-03-06 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-15 04:35 pm | Q4 2023 Sales and Revenue Release |
| 2023-11-20 | Q3 2023 Sales and Revenue Release After hours |
| 2023-11-13 | Stifel Healthcare Conference |
| 2023-11-09 | AASLD Liver Meeting |
| 2023-10-23 | H.C. Wainwright NASH Investor Conference |
| 2023-10-18 | MOSAIC Meeting |
| 2023-10-11 | Roth Healtcare Opportunities Conference |
| 2023-10-03 | Portzamparc BNP Paribas Healthcare Conference |
| 2023-09-29 08:00 am | Q2 2023 Earnings Call |
| 2023-09-28 04:00 pm | Q2 2023 Earnings Release |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-07-27 04:00 pm | Q2 2023 Sales and Revenue Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 7,00 4,42 58.45% | 0,37 1,53 -75.72% | 4,20 5,13 -18.06% | 12,2 12,0 1.72% | 17,5 9,44 85.12% | 4,24 |
|
EBITDA Million EUR | Released Forecast Spread | -28,7 -33,1 13.19% | -27,8 -30,2 7.98% | -51,3 -48,8 -5.13% | -55,4 -66,8 17.03% | 0,00 -90,2 - | -95,8 |
|
EBIT Million EUR | Released Forecast Spread | -30,3 -38,7 21.62% | -29,7 -34,5 13.82% | -51,2 -52,4 2.29% | -57,1 -58,6 2.56% | -103 -86,7 -18.5% | -115 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -30,2 -38,0 20.41% | -33,6 -34,6 2.72% | -49,3 -52,3 5.7% | -54,3 -63,1 13.94% | -110 -96,7 -13.6% | -123 |
|
Net income Million EUR | Released Forecast Spread | -30,2 -37,7 19.82% | -33,6 -34,5 2.58% | -49,6 -52,5 5.39% | -54,3 -56,2 3.37% | -110 -88,8 -24.32% | -113 |
|
EPS EUR | Released Forecast Spread | -1,28 -1,55 17.42% | -0,99 -1,00 0.62% | -1,27 -1,25 -1.55% | -1,31 -1,62 18.97% | -2,43 -2,15 -13.29% | -1,59 |
| Announcement Date | 10/03/20 | 04/03/21 | 14/02/22 | 29/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 Q2 | 2023 S1 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5,67 3,05 85.74% | 1,77 2,50 -29.33% | 0,21 0,10 111% | 0,14 0,07 108.49% | 4,06 3,36 20.77% | 0,10 1,07 -90.63% | 12,1 13,0 -6.92% | 1,90 1,39 37.2% | 1,90 0,76 149.18% | 15,6 1,37 1033.45% | 15,6 9,69 60.78% | 1,39 | 1,39 | 3,08 | 1,39 | 1,39 | 3,42 |
|
EBITDA Million EUR | Released Forecast Spread | -25,2 | -16,2 | -23,0 | -25,3 | -26,3 | -24,5 | |||||||||||
|
EBIT Million EUR | Released Forecast Spread | -9,66 -20,3 52.39% | -15,7 -15,9 1.4% | -14,1 -16,3 13.6% | -23,2 -17,8 -30.24% | -28,0 -29,8 6.16% | -33,5 -34,8 3.9% | -23,6 -27,6 14.34% | -25,2 | -55,0 -39,8 -38.14% | -16,2 | -47,7 -42,8 -11.5% | -23,0 | -25,3 | -62,5 | -26,3 | -24,5 | -63,6 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -9,67 -20,1 51.82% | -15,7 -15,3 -2.14% | -18,0 -16,5 -9.02% | -22,8 -26,9 15.19% | -26,5 -31,4 15.62% | -29,5 -34,8 15.29% | -24,8 -27,9 11.08% | -55,3 -40,6 -36.09% | -54,5 -42,3 -29.1% | -60,8 | -62,2 | ||||||
|
Net income Million EUR | Released Forecast Spread | -9,67 -20,1 51.76% | -15,7 -15,3 -2.14% | -18,0 -16,4 -9.51% | -23,1 -26,9 13.86% | -26,5 -31,5 15.77% | -29,5 -34,8 15.34% | -24,8 -27,9 11.08% | -55,3 -39,8 -38.77% | -55,2 -42,3 -30.55% | -60,8 | -62,2 | ||||||
|
EPS EUR | Released Forecast Spread | -0,35 -0,86 59.06% | -0,52 -0,54 4.15% | -0,47 -0,51 7.39% | -0,60 -0,77 22.08% | -0,67 -0,81 16.94% | -0,72 -0,84 14.62% | -0,59 -0,60 1.67% | -1,31 -0,90 -46.37% | -1,12 -0,79 -41.77% | -0,77 | -0,62 | ||||||
| Announcement Date | 10/03/20 | 16/09/20 | 04/03/21 | 20/09/21 | 14/02/22 | 22/09/22 | 29/03/23 | 27/07/23 | 27/07/23 | 27/03/24 | 27/03/24 | - | - | - | - | - | - |
More events
Past sector events for Inventiva
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IVA Stock
- Calendar Inventiva
